HIV-1 Immune Escape Maps Figure 7. HLA-B*27-associated escape and covariation pathways in HIV-1 Gag. doi:10.1371/journal.pone.0006687.g007 5. Carrington M, O’Brien SJ (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 535–551. 6. Goulder PJ, Watkins DI (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8: 619–630. 7. Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, et al. (2008) HIV vaccine research: the way forward. Science 321: 530–532. 8. Johnston MI, Fauci AS (2008) An HIV vaccine–challenges and prospects. N Engl J Med 359: 888–890. 9. Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC (2008) Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat Med 14: 617–621. 10. Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320: 760–764. 11. Letvin NL (2007) Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 27: 366–369. 12. Klein J, Sato A (2000) The HLA system. First of two parts. N Engl J Med 343: 702–709. 13. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641–645. 14. Moore CB, John M, James IR, Christiansen FT, Witt CS, et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439–1443. 15. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, et al. (2007) Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1. PLoS Pathog 3: e94. 16. Iversen AK, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, et al. (2006) Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol 7: 179–189. 17. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, et al. (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3: 205–211. 18. Koup RA (1994) Virus escape from CTL recognition. J Exp Med 180: 779–782. 19. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, et al. (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 94: 1890–1895. 20. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453–459. 21. Allen TM, Altfeld M, Yu XG, O’Sullivan KM, Lichterfeld M, et al. (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T- lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78: 7069–7078. PLoS ONE | www.plosone.org 11 August 2009 | Volume 4 | Issue 8 | e6687